Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Midodrine and Fludrocortisone in Patients with Septic Shock
IRCT20250504065597N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of midodrine and fludrocortisone in septic shock, sponsored by Tabriz University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
midodrinefludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20250504065597N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250504065597N1.